相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Focus on cutaneous and uveal melanoma specificities
Charlotte Pandiani et al.
GENES & DEVELOPMENT (2017)
Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma
Paola Falletta et al.
GENES & DEVELOPMENT (2017)
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression
Caroline Bonet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression
Caroline Bonet et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Marjolein P. Baar et al.
CELL (2017)
SUMO and the robustness of cancer
Jacob-Sebastian Seeler et al.
NATURE REVIEWS CANCER (2017)
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Jianhui Chang et al.
NATURE MEDICINE (2016)
Genetics of melanoma progression: the rise and fall of cell senescence
Dorothy C. Bennett
PIGMENT CELL & MELANOMA RESEARCH (2016)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors
Yi Zhu et al.
AGING CELL (2016)
Genetic Modifiers of the p53 Pathway
Subhasree Basu et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations
Miriam Potrony et al.
JAMA DERMATOLOGY (2016)
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16INK4a) in Cancer
Ran Zhao et al.
EBIOMEDICINE (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Clinical strategies and animal models for developing senolytic agents
James L. Kirkland et al.
EXPERIMENTAL GERONTOLOGY (2015)
Defining the Contribution of MC1R Physiological Ligands to ATR Phosphorylation at Ser435, a Predictor of DNA Repair in Melanocytes
Stuart G. Jarrett et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
Michael Krauthammer et al.
NATURE GENETICS (2015)
Recurrent inactivating RASA2 mutations in melanoma
Rand Arafeh et al.
NATURE GENETICS (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Genetics of familial melanoma: 20 years after CDKN2A
Lauren G. Aoude et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model
Lionel Larribere et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9
Bing Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity
Alejandro Conde-Perez et al.
NATURE COMMUNICATIONS (2015)
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
Stefanie Riesenberg et al.
NATURE COMMUNICATIONS (2015)
Germline Mutations in the CDKN2B Tumor Suppressor Gene Predispose to Renal Cell Carcinoma
Mariam Jafri et al.
CANCER DISCOVERY (2015)
CDKN2B Loss Promotes Progression from Benign Melanocytic Nevus to Melanoma
Andrew S. McNeal et al.
CANCER DISCOVERY (2015)
Advances in the development of SUMO specific protease (SENP) inhibitors
Ashutosh Kumar et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
Telomere-Regulating Genes and the Telomere Interactome in Familial Cancers
Carla Daniela Robles-Espinoza et al.
MOLECULAR CANCER RESEARCH (2015)
The Molecular Pathology of Melanoma: An Integrated Taxonomy of Melanocytic Neoplasia
Boris C. Bastian
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Oxidative stress in melanocyte senescence and melanoma transformation
Svenja Meierjohann
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
A germline oncogenic MITF mutation and tumor susceptibility
Brigitte Bressac-de Paillerets et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2014)
Phenotypic Characterization of Nevus and Tumor Patterns in MITF E318K Mutation Carrier Melanoma Patients
Richard A. Sturm et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53
Amaya Viros et al.
NATURE (2014)
Significance of the melanocortin 1 receptor in the DNA damage response of human melanocytes to ultraviolet radiation
Viki Swope et al.
PIGMENT CELL & MELANOMA RESEARCH (2014)
A short acidic motif in ARF guards against mitochondrial dysfunction and melanoma susceptibility
Claus Christensen et al.
NATURE COMMUNICATIONS (2014)
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma
Judith Mueller et al.
NATURE COMMUNICATIONS (2014)
The Genetic Landscape of Clinical Resistance to RAF Inhibition in Metastatic Melanoma
Eliezer M. Van Allen et al.
CANCER DISCOVERY (2014)
A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
David J. Konieczkowski et al.
CANCER DISCOVERY (2014)
The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs
Guillaume Bossis et al.
CELL REPORTS (2014)
Human nevi lack distinguishing senescence traits
Sieu Tran et al.
AGING-US (2013)
Targeting aurora kinases limits tumour growth through DNA damage-mediated senescence and blockade of NF-?B impairs this drug-induced senescence
Yan Liu et al.
EMBO MOLECULAR MEDICINE (2013)
Vemurafenib Induces Senescence Features in Melanoma Cells
Sebastian Haferkamp et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
MC1R Is a Potent Regulator of PTEN after UV Exposure in Melanocytes
Juxiang Cao et al.
MOLECULAR CELL (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
Synthetic lethal metabolic targeting of cellular senescence in cancer therapy
Jan R. Doerr et al.
NATURE (2013)
Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history
P. Ghiorzo et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression
Alastair D. MacKenzie Ross et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
p16INK4a deficiency promotes DNA hyper-replication and genetic instability in melanocytes
Carina Fung et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
RAC1P29S is a spontaneously activating cancer-associated GTPase
Matthew J. Davis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Challenging resistance mechanisms to therapies for metastatic melanoma
Lucio Tentori et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype
Mickal Ohanna et al.
ONCOTARGET (2013)
Concurrent MEK2 Mutation and BRAF Amplification Confer Resistance to BRAF and MEK Inhibitors in Melanoma
Jessie Villanueva et al.
CELL REPORTS (2013)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions
Anitha Suram et al.
EMBO JOURNAL (2012)
Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis
Liesbeth C. W. Vredeveld et al.
GENES & DEVELOPMENT (2012)
Activated Mutant NRasQ61K Drives Aberrant Melanocyte Signaling, Survival, and Invasiveness via a Rac1-Dependent Mechanism
Ang Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
Michael Krauthammer et al.
NATURE GENETICS (2012)
PP2A-B56α controls oncogene-induced senescence in normal and tumor human melanocytic cells
S. Mannava et al.
ONCOGENE (2012)
Rac1 in the driver's seat for melanoma
Laura M. Machesky et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis
Jessica D. Kessler et al.
SCIENCE (2012)
Phosphatidylinositol 3′-kinase signaling pathway is essential for Rac1-induced hypoxia-inducible factor-1α and vascular endothelial growth factor expression
Yan Xue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas
William E. Damsky et al.
CANCER CELL (2011)
Senescent cells develop a PARP-1 and nuclear factor-κB-associated secretome (PNAS)
Mickael Ohanna et al.
GENES & DEVELOPMENT (2011)
Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype
Jean-Philippe Coppe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Satoru Yokoyama et al.
NATURE (2011)
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Corine Bertolotto et al.
NATURE (2011)
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Darren J. Baker et al.
NATURE (2011)
Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma
T. Strub et al.
ONCOGENE (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Mechanisms, regulation and consequences of protein SUMOylation
Kevin A. Wilkinson et al.
BIOCHEMICAL JOURNAL (2010)
Microphthalmia-Associated Transcription Factor Controls the DNA Damage Response and a Lineage-Specific Senescence Program in Melanomas
Sandy Giuliano et al.
CANCER RESEARCH (2010)
IGFBP7 Is Not Required for B-RAF-Induced Melanocyte Senescence
Lyndee L. Scurr et al.
CELL (2010)
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study
F. Demenais et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Feedback between p21 and reactive oxygen production is necessary for cell senescence
Joao F. Passos et al.
MOLECULAR SYSTEMS BIOLOGY (2010)
The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition
Jaclyn R. Gareau et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Fifteen-year quest for microphthalmia-associated transcription factor target genes
Yann Cheli et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
Tamara Terzian et al.
PIGMENT CELL & MELANOMA RESEARCH (2010)
The relative contributions of the p53 and pRb pathways in oncogene induced melanocyte senescence
Sebastian Haferkamp et al.
AGING-US (2009)
SUMOylation and cell signalling
Artemisia M. Andreou et al.
Biotechnology Journal (2009)
Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice
Nathalie Dhomen et al.
CANCER CELL (2009)
A two-step model for senescence triggered by a single critically short telomere
Pauline Abdallah et al.
NATURE CELL BIOLOGY (2009)
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Francis Rodier et al.
NATURE CELL BIOLOGY (2009)
BrafV600E cooperates with Pten loss to induce metastatic melanoma
David Dankort et al.
NATURE GENETICS (2009)
Melanocytic nevus-like hyperplasia and melanoma in transgenic BRAFV600E mice
V. K. Goel et al.
ONCOGENE (2009)
A genomic screen identifies TYRO3 as a MITF regulator in melanoma
Shoutian Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Senescence-messaging secretome: SMS-ing cellular stress
Thomas Kuilman et al.
NATURE REVIEWS CANCER (2009)
p16(INK4a)-induced senescence is disabled by melanoma-associated mutations
Sebastian Haferkamp et al.
AGING CELL (2008)
A novel AKT3 mutation in melanoma tumours and cell lines
M. A. Davies et al.
BRITISH JOURNAL OF CANCER (2008)
Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network
Thomas Kuilman et al.
CELL (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Chemokine signaling via the CXCR2 receptor reinforces senescence
Juan C. Acosta et al.
CELL (2008)
Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies
Yu-Qian Zhang et al.
JOURNAL OF CELL BIOLOGY (2008)
C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells
D. Zhuang et al.
ONCOGENE (2008)
β-Catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development
Veronique Delmas et al.
GENES & DEVELOPMENT (2007)
DNA damage response as an anti-cancer barrier - Damage threshold and the concept of 'conditional haploinsufficiency'
Jiri Bartek et al.
CELL CYCLE (2007)
Nevus size and number are associated with telomere length and represent potential markers of a decreased senescence in vivo
Veronique Bataille et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence
Linan Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Wen Xue et al.
NATURE (2007)
Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations
Juergen Bauer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence
Frederick A. Mallette et al.
GENES & DEVELOPMENT (2007)
Mitf regulation of Dia1 controls melanoma proliferation and invasiveness
Suzanne Carreira et al.
GENES & DEVELOPMENT (2006)
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Raffaella Di Micco et al.
NATURE (2006)
Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway
Christophe Denoyelle et al.
NATURE CELL BIOLOGY (2006)
Cellular senescence in naevi and immortalisation in melanoma: a role for p16?
V. C. Gray-Schopfer et al.
BRITISH JOURNAL OF CANCER (2006)
Skin hypoxia - A promoting environmental factor in melanomagenesis
Barbara Bedogni et al.
CELL CYCLE (2006)
The WNT/beta-catenin pathway in melanoma
L Larue et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Sumoylation modulates transcriptional activity of MITF in a promoter-specific manner
H Murakami et al.
PIGMENT CELL RESEARCH (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background
J Ackermann et al.
CANCER RESEARCH (2005)
The signals and pathways activating cellular senescence
I Ben-Porath et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
EE Patton et al.
CURRENT BIOLOGY (2005)
Sumoylation of MITF and its related family members TFE3 and TFEB
AJ Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma
H Tsao et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes
A Sonnenblick et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Melanocytes and the Microphthalmia transcription factor network
E Steingrimsson et al.
ANNUAL REVIEW OF GENETICS (2004)
Reversal of human cellular senescence:: roles of the p53 and p16 pathways
CM Beauséjour et al.
EMBO JOURNAL (2003)
p16/cyclin-dependent kinase inhibitor 2A deficiency in human melanocyte senescence, apoptosis, and immortalization: Possible implications for melanoma progression
EV Sviderskaya et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Ultraviolet radiation and cutaneous malignant melanoma
C Jhappan et al.
ONCOGENE (2003)
PTEN signaling pathways in melanoma
H Wu et al.
ONCOGENE (2003)
The longer your telomeres, the larger your nevus?
BC Bastian
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Role played by microphthalmia transcription factor phosphorylation and its zip domain in its transcriptional inhibition by PIAS3
C Levy et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
β-Catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor
HR Widlund et al.
JOURNAL OF CELL BIOLOGY (2002)
A genome-based strategy uncovers frequent BRAF mutations in melanoma
PM Pollock et al.
CANCER CELL (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Germline mutation of ARF in a melanoma kindred
C Hewitt et al.
HUMAN MOLECULAR GENETICS (2002)
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
CA Schmitt et al.
CELL (2002)
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations
NF Box et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
A melanoma-associated germline mutation in exon 1β inactivates p14ARF
H Rizos et al.
ONCOGENE (2001)
Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features
BC Bastian et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
分享论文
